Méningiomes et progestatifs
Marie‐Laure Raffin‐Sanson(Hôpital Cochin), Michel Kalamarides(Centre National de la Recherche Scientifique), I. Lemaire-Martin(Hôpital Ambroise-Paré), Franck Bielle(Centre National de la Recherche Scientifique), Chiara Villa(Centre National de la Recherche Scientifique), Mathilde Sanson(Centre National de la Recherche Scientifique), C. De Marcellus(Hôpital Ambroise-Paré), Anne‐Laure Boch(Sorbonne Université), Marion Peyre(Centre National de la Recherche Scientifique), Laure Cazabat(Hôpital Foch), S. Gaillard(Hôpital Foch), Cristina Birzu(Centre National de la Recherche Scientifique), H. Loiseau(Centre Hospitalier Universitaire de Bordeaux), Bertrand Baussart(Centre National de la Recherche Scientifique)
Cited by 0
Related Papers
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study
|The Journal of Clinical Endocrinology & Metabolism|2010|374
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
|Endocrine Related Cancer|2017|357
Gigantism and Acromegaly Due to Xq26 Microduplications and <i>GPR101</i> Mutation
|New England Journal of Medicine|2014|340
Pangenomic Classification of Pituitary Neuroendocrine Tumors
|Cancer Cell|2019|335
BRAF Inhibition in <i>BRAF</i> <sup>V600</sup> -Mutant Gliomas: Results From the VE-BASKET Study
|Journal of Clinical Oncology|2018|330